Aby J. Mathew - 11 Jul 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Signature
/s/ Aby J. Mathew
Issuer symbol
BLFS
Transactions as of
11 Jul 2024
Net transactions value
-$17,888
Form type
4
Filing time
18 Sep 2024, 17:45:12 UTC
Previous filing
31 May 2024
Next filing
20 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $6,429 -313 -0.1% $20.54 318,170 11 Jul 2024 Direct F1
transaction BLFS Common Stock Sale $2,843 -111 -0.03% $25.61 318,059 21 Aug 2024 Direct F2
transaction BLFS Common Stock Sale $8,616 -343 -0.11% $25.12 317,716 16 Sep 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F3 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.